This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox.

I’m just back from the ASH meeting in Orlando, so a shorter-than-normal newsletter this week.

“Mean Adam” is also back. You’ll see below.

To read the rest of this story subscribe to STAT+. Subscribe Log In

See Full Page